|
1.
|
Stein JP, Lieskovsky G, Cote R, et al:
Radical cystectomy in the treatment of invasive bladder cancer:
Long-term results in 1,054 patients. J Clin Oncol. 19:666–675.
2001.PubMed/NCBI
|
|
2.
|
Mills RD, Turner WH, Fleischmann A,
Markwalder R, Thalmann GN and Studer UE: Pelvic lymph node
metastases from bladder cancer: outcome in 83 patients after
radical cystectomy and pelvic lymphadenectomy. J Urol. 166:19–23.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Vieweg J, Gschwend JE, Herr HW and Fair
WR: The impact of primary stage on survival in patients with lymph
node positive bladder cancer. J Urol. 161:72–76. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Vieweg J, Gschwend JE, Herr HW and Fair
WR: Pelvic lymph node dissection can be curative in patients with
node positive bladder cancer. J Urol. 161:449–454. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Azuma H, Inamoto T, Takahara K, et al: A
great option for elderly patients with locally invasive bladder
cancer, BOAI-CDDP-radiation (OMC regimen). Int J Oncol.
43:1087–1094. 2013.PubMed/NCBI
|
|
6.
|
Azuma H, Inamoto T, Takahara K, et al:
Effect of a novel bladder preservation therapy, BOAI-CDDP–radiation
(OMC-regimen). Int J Oncol. 43:79–87. 2013.
|
|
7.
|
Azuma H, Inamoto T, Ibuki N, et al:
Utility of the novel bladder preservation therapy,
BOAI-CDDP-radiation (OMC-regimen), for elderly patients with
invasive bladder cancer. Int J Oncol. 38:13–24. 2011.PubMed/NCBI
|
|
8.
|
Azuma H, Inamoto T, Ibuki N, et al: Novel
bladder preservation therapy for locally invasive bladder cancer:
combined therapy using balloon-occluded arterial infusion of
anticancer agent and hemodialysis with concurrent radiation. Int J
Oncol. 37:773–785. 2010. View Article : Google Scholar
|
|
9.
|
Azuma H, Yamamoto K, Inamoto T, et al:
Total cystectomy versus bladder preservation therapy for locally
invasive bladder cancer: effect of combined therapy using
balloon-occluded arterial infusion of anticancer agent and
hemodialysis with concurrent radiation. Am J Clin Oncol.
32:592–606. 2009. View Article : Google Scholar
|
|
10.
|
Azuma H, Kotake Y, Yamamoto K, et al:
Effect of combined therapy using balloon-occluded arterial infusion
of cisplatin and hemodialysis with concurrent radiation for locally
invasive bladder cancer. Am J Clin Oncol. 31:11–21. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Greene FL, Page DL and Fleming ID: AJCC
Cancer Staging Manual . 6th edition. Springer Verlag; New York:
2002, View Article : Google Scholar
|
|
12.
|
Bassi P, Ferrante GD, Piazza N, et al:
Prognostic factors of outcome after radical cystectomy for bladder
cancer: a retrospective study of a homogeneous patient cohort. J
Urol. 161:1494–1497. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Madersbacher S, Hochreiter W, Burkhard F,
et al: Radical cystectomy for bladder cancer today - a homogeneous
series without neoadjuvant therapy. J Clin Oncol. 21:690–696. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Shariat SF, Karakiewicz PI, Palapattu GS,
et al: Outcomes of radical cystectomy for transitional cell
carcinoma of the bladder: a contemporary series from the Bladder
Cancer Research Consortium. J Urol. 176:2414–2422. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Stockle M, Wellek S, Meyenburg W, et al:
Radical cystectomy with or without adjuvant polychemotherapy for
non-organ-confined transitional cell carcinoma of the urinary
bladder: prognostic impact of lymph node involvement. Urology.
48:868–875. 1996. View Article : Google Scholar
|
|
16.
|
Herr HW, Bochner BH, Dalbagni G, Donat SM,
Reuter VE and Bajorin DF: Impact of the number of lymph nodes
retrieved on outcome in patients with muscle invasive bladder
cancer. J Urol. 167:1295–1298. 2002. View Article : Google Scholar
|
|
17.
|
Stein JP, Cai J, Groshen S and Skinner DG:
Risk factors for patients with pelvic lymph node metastases
following radical cystectomy with en bloc pelvic lymphadenectomy:
concept of lymph node density. J Urol. 170:35–41. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Herr HW: Superiority of ratio based lymph
node staging for bladder cancer. J Urol. 169:943–945. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Cheng CW, Ng CF, Chan CK, Wong WS, Hui PE
and Wong YF: A fourteen-year review of radical cystectomy for
transitional cell carcinoma demonstrating the usefulness of the
concept of lymph node density. Int Braz J Urol. 32:536–549.
2006.
|
|
20.
|
Kassouf W, Agarwal PK, Herr HW, et al:
Lymph node density is superior to TNM nodal status in predicting
disease-specific survival after radical cystectomy for bladder
cancer: analysis of pooled data from MDACC and MSKCC. J Clin Oncol.
26:121–126. 2008. View Article : Google Scholar
|
|
21.
|
Dhar NB, Klein EA, Reuther AM, Thalmann
GN, Madersbacher S and Studer UE: Outcome after radical cystectomy
with limited or extended pelvic lymph node dissection. J Urol.
179:873–878. 2008. View Article : Google Scholar
|
|
22.
|
Konety BR, Joslyn SA and O’Donnell MA:
Extent of pelvic lymphadenectomy and its impact on outcome in
patients diagnosed with bladder cancer: analysis of data from the
Surveillance, Epidemiology and End Results Program data base. J
Urol. 169:946–950. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Leissner J, Ghoneim MA, Abol-Enein H, et
al: Extended radical lymphadenectomy in patients with urothelial
bladder cancer: results of a prospective multicenter study. J Urol.
171:139–144. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Koppie TM, Vickers AJ, Vora K, Dalbagni G
and Bochner BH: Standardization of pelvic lymphadenectomy performed
at radical cystectomy: can we establish a minimum number of lymph
nodes that should be removed? Cancer. 107:2368–2374. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
No authors listed: Neoadjuvant cisplatin,
methotrexate, and vinblastine chemotherapy for muscle-invasive
bladder cancer: a randomised controlled trial. International
collaboration of trialists Lancet. 354:533–540. 1999.
|
|
26.
|
Grossman HB, Natale RB, Tangen CM, et al:
Neoadjuvant chemotherapy plus cystectomy compared with cystectomy
alone for locally advanced bladder cancer. N Engl J Med.
349:859–866. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Advanced Bladder Cancer Meta-analysis
Collaboration: Neoadjuvant chemotherapy in invasive bladder cancer:
a systematic review and meta-analysis. Lancet. 361:1927–1934. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Winquist E, Kirchner TS, Segal R, Chin J
and Lukka H: Neoadjuvant chemotherapy for transitional cell
carcinoma of the bladder: a systematic review and meta-analysis. J
Urol. 171:561–569. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Collins JM: Pharmacokinetic rationale for
intraarterial therapy. Cancer Chemotherapy, Challenges for the
Future. Kimura K: 4. Excepta Medica, Amsterdam; 1989
|
|
30.
|
Mitsuzane K, Kawabata M, Terada M, Nomura
S, Sato M and Yamada R: Balloon-occluded arterial infusion as
chemotherapy in bladder cancer-long-term results. Gan To Kagaku
Ryoho. 17:1701–1704. 1990.(In Japanese).
|
|
31.
|
Talley RW, O’Bryan RM, Gutterman JU,
Brownlee RW and McCredie KB: Clinical evaluation of toxic effects
of cis-diamminedichloroplatinum (NSC-119875) - phase I clinical
study. Cancer Chemother Rep. 57:465–471. 1973.PubMed/NCBI
|
|
32.
|
Cvitkovic E, Spaulding J, Bethune V,
Martin J and Whitmore WF: Improvement of
cis-dichlorodiammineplatinum (NSC 119875): therapeutic index in an
animal model. Cancer. 39:1357–1361. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Abol-Enein H, El-Baz M, Abd El-Hameed MA,
Abdel-Latif M and Ghoneim MA: Lymph node involvement in patients
with bladder cancer treated with radical cystectomy: a
patho-anatomical study - a single center experience. J Urol.
172:1818–1821. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Vazina A, Dugi D, Shariat SF, Evans J,
Link R and Lerner SP: Stage specific lymph node metastasis mapping
in radical cystectomy specimens. J Urol. 171:1830–1834. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Douple EB and Richmond RC: A review of
platinum complex biochemistry suggests a rationale for combined
platinum-radiotherapy. Int J Radiat Oncol Biol Phys. 8:1335–1339.
1979. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Douple EB and Richmond RC:
Radiosensitization of hypoxic tumor cells by cis- and
trans-dichlorodiammineplatinum (II). Int J Radiat Oncol Biol Phys.
5:1369–1372. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Abbott DW, Freeman ML and Holt JT:
Double-strand break repair deficiency and radiation sensitivity in
BRCA2 mutant cancer cells. J Natl Cancer Inst. 90:978–985. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Brown JM and Wouters BG: Apoptosis, p53,
and tumor cell sensitivity to anticancer agents. Cancer Res.
59:1391–1399. 1999.PubMed/NCBI
|
